Litcius/Paper detail

A Prospective Cohort Comparative Study of Rivaroxaban, Dabigatran, and Apixaban Oral Thromboprophylaxis in 2431 Hip and Knee Arthroplasty Patients: Primary Efficacy Outcomes and Safety Profile

Alan J. Highcock, Mohammed As-Sultany, Rosemary Finley, N.J. Donnachie

2020The Journal of Arthroplasty24 citationsDOI

Topics & Concepts

ApixabanDabigatranMedicineRivaroxabanDeep veinWarfarinThrombosisInternal medicineAnesthesiaSurgeryAtrial fibrillationVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesTotal Knee Arthroplasty Outcomes
A Prospective Cohort Comparative Study of Rivaroxaban, Dabigatran, and Apixaban Oral Thromboprophylaxis in 2431 Hip and Knee Arthroplasty Patients: Primary Efficacy Outcomes and Safety Profile | Litcius